Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELEMENTOS LIMITED Share Issue/Capital Change 2014

Mar 19, 2014

64837_rns_2014-03-19_a417d106-64aa-4ca3-bf8c-2d98bf9c1639.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix 3B – New Issue Announcement

\Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity

ELEMENTOS LIMITED

ABN

49 138 468 756

We (the entity) give ASX the following information:

Part 1 - All issues

1
Class of securities issued or to be issued
2
Number of securities issued or to be issued (if
known) or maximum number which may be issued
3
Principal terms of the securities
4
Do the securities rank equally in all respects from the
date of allotment with an existing class of quoted
securities?
5
Issue price or consideration
6
Purpose of the issue
6a
Is the entity an eligible entity that has obtained
security holder approval under rule 7.1A?
6b
The date the security holder resolution under rule
7.1A was passed
6c
Number of securities issued without security holder
approval under rule 7.1
6d
Number of securities issued with security holder
approval under rule 7.1A
OrdinaryShares
1. 15,000,000
2. 887,923
Asper existingordinaryshares
Yes
1. A$.02
2. A$0.01608
1. Provide funds to advance the Cleveland
Project and working capital.
2. Issue of shares under Director &
Executive Staff Salary Sacrifice Plans.
Yes
16 November 2012
Nil
Nil

Appendix 3B – New Issue Announcement

6e
Number of securities issued with security holder
approval under rule 7.3, or another specific security
holder approval (specify date of meeting)
6f
Number of securities issued under an exception in
rule 7.2
6g
If securities issued under rule 7.1A, was issue price
at least 75% of 15 day VWAP as calculated under
rule 7.1A.3? Include the issue date and both values.
Include the source of the VWAP calculation.
6h
If securities were issued under rule 7.1A for non-
cash consideration, state date on which valuation of
consideration
was
released
to
ASX
Market
Announcements
6i
Calculate the entity’s remaining issue capacity under
rule 7.1 and rule 7.1A – complete Annexure 1 and
release to ASX Market Announcements
7
Dates of entering securities into uncertificated
holdings or despatch of certificates.
8
Number and class of all securities quoted on ASX
9
Number and class of all securities not quoted on
ASX
10
Dividend policy on the increased capital (interests)
1. 15,000,000
2. 887,923
1. 15,000,000
2. 887,923
Nil

N/A
N/A
LR 7.1: 82,738,380
LR7.1A: 55,158,920
18 July 2013
**Number ** Class
551,589,200
32,952,052
Ordinary Shares
Options
Number
Class
4,500,000
550,000
500,000
1,000,000
200,000
2,350,000
Options
exercisable
at $0.226 expiring 23
October 2015
Options
exercisable
at $0.226 expiring 7
September 2015
Options
exercisable
at $0.226 expiring 30
November 2015
Options
exercisable
at $0.326 expiring 18
January 2017
Options
exercisable
at $0.06 expiring 3
December 2016
Options
exercisable
at $0.06 expiring 20
January 2017
Not Applicable

Part 2 - Bonus issue or pro rata issue

Appendix 3B – New Issue Announcement

11 Is security holder approval required?
12 Is the issue renounceable or non-renounceable?
13 Ratio in which the securities will be offered
14 Class of securities to which the offer relates
15 Record date to determine entitlements
16 Will holdings on different registers (or subregisters)
be aggregated for calculating entitlements?
17 Policy for deciding entitlements in relation to
fractions
18 Names of countries in which the entity has
security holders who will not be sent new issue
documents
19 Closing
date
for
receipt
of
acceptances
or
renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or commission
22 Names of any brokers to the issue
23 Fee or commission payable to the broker to the issue
24 Amount of any handling fee payable to brokers who
lodge acceptances or renunciations on behalf of
security holders
25 If the issue is contingent on security holders’
approval, the date of the meeting
26 Date entitlement and acceptance form and prospectus
or Product Disclosure Statement will be sent to
persons entitled
27 If the entity has issued options, and the terms entitle
option holders to participate on exercise, the date on
which notices will be sent to option holders
28 Date rights trading will begin (if applicable)
29 Date rights trading will end (if applicable)
30 How do security holders sell their entitlements in full
through a broker?
31 How do security holders sell part of their
entitlements through a broker and accept for the
balance?

Appendix 3B – New Issue Announcement

  • 32 How do security holders dispose of their entitlements (except by sale through a broker)?

  • 33 Despatch date

Part 3 - Quotation of securities

34 Type of securities ( tick one )

  • (a) X Securities described in Part 1

  • (b) All other securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the securities are equity securities, the names of the 20 largest holders of the additional
securities, and the number and percentage of additional securities held by those holders
36 If the securities are equity securities, a distribution schedule of the additional securities setting
out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional securities

Entities that have ticked box 34(b)

38
Number of securities for which quotation is sought
39
Class of securities for which quotation is sought
40
Do the securities rank equally in all respects from
the date of allotment with an existing class of
quoted securities?
If not, please state:
• the date from which they do
• the extent to which they participate for the next
dividend, or interest payment
• the extent to which they do not rank equally,
other than in relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation now
42
Number and class of all securities quoted on ASX
(_including_the securities in clause 38)
**Number ** Class

Appendix 3B – New Issue Announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for[+] eligible entities

Introduced 01/08/12

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Rule 7.1 – Issues exceeding 15% of capital Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insertnumber of fully paid ordinary securities on issue 12
months before date of issue or agreement to issue
149,531,420
Addthe following:
• Number of fully paid ordinary securities issued in that
12 month period under an exception in rule 7.2
• Number of fully paid ordinary securities issued in that
12 month period with shareholder approval
• Number of partly paid ordinary securities that became
fully paid in that 12 month period
286,202,262
115,855,518
Nil
Subtractthe number of fully paid ordinary securities
cancelled during that 12 month period
Nil
“A” 551,589,200
Step 2: Calculate 15% of “A”
“B” 0.15
Multiply“A” by 0.15 82,738,380
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been
used
Insertnumber of equity securities issued or agreed to be
issued in that 12 month period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule 7.1 or rule 7.4
Nil
“C” Nil
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 82,738,380
Subtract“C” Nil
Total[“A” x 0.15] – “C” 82,738,380

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
“A” (number must be same as shown in Step 1 of Part )
551,589,200

Appendix 3B – New Issue Announcement

Step 2: Calculate 10% of “A”
“D” 0.10
Multiply“A” by 0.10 55,158,920
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been
used
Insertnumber of equity securities issued or agreed to be
issued in that 12 month period under rule 7.1A
Nil
“E” Nil
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule
7.1A
“A” x 0.10 (number must be same as shown in Step 2) 55,158,920
Subtract“E” (number must be same as shown in Step 3) Nil
Total[“A” x 0.10] – “E” 55,158,920

Quotation agreement

  • 1 Quotation of our additional securities is in ASX’s absolute discretion. ASX may quote the securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those securities should not be granted quotation.

  • An offer of the securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any securities to be quoted and that no-one has any right to return any securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the securities be quoted.

  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the securities to be quoted, it has been provided at the time that we request that the securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the securities to be quoted under section 1019B of the Corporations Act at the time that we request that the securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before quotation of the securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [103 x 46] intentionally omitted <==

Sign here: Date: 20 March 2014 Company Secretary

Print name: Linda Scott